In Blunt Response, Open Biosystems Defends Itself Against Sigma-Aldrich Suit | GenomeWeb
NEW YORK, June 15 (GenomeWeb News) - Open Biosystems today responded to a patent-infringement suit filed against it by Sigma-Aldrich and Oxford BioMedica, framing the dispute in David vs. Goliath terms.
 
The company also said it plans to "defend these claims" and "reaffirmed its dedication" to The RNAi Consortium lentiviral libraries at the heart of the suit.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.